Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

54.33
Delayed Data
As of Jul 25
 -0.40 / -0.73%
Today’s Change
48.01
Today|||52-Week Range
72.31
-17.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues20.3B20.4B20.3B19.6B
 
 
 
 
 
Cost of Goods Sold8.0B8.0B7.7B7.0B
 
 
 
 
 
Depreciation And Amortization1.7B1.6B1.5B1.3B
 
 
 
 
 
 
Operating ExpensesGross Income10.6B10.7B11.1B11.3B
 
 
 
 
 
General Expenses6.5B6.8B6.6B6.2B
 
 
 
 
 
Other Operating Expenses0.0027.1M17.0M0.00
 
 
 
Research And Development1.4B1.4B1.5B1.5B
 
 
 
 
 
Total Operating Expenses16.1B16.4B15.8B14.5B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.2B3.9B4.5B5.1B
 
 
 
 
 
Extraordinary Credit40.0M--237.0M53.0M
 
 
 
 
Extraordinary Charge-2.0B-2.3B-633.0M-2.4B
 
 
 
 
 
Interest Expense On Debt386.8M424.2M435.0M464.8M
 
 
 
 
 
Equity In Earnings-46.0M-40.1M-5.0M-121.0M
 
 
 
 
 
Other Expenses-25.0M-8.0M-30.0M60.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.8B1.3B3.6B2.4B
 
 
 
 
 
Income Taxes-136.9M-43.1M-591.0M-633.8M
 
 
 
 
 
Minority Interest-53.0M-16.0M-13.0M-9.0M
 
 
 
 
 
Preferred Dividend0.000.000.00-15.0M
 
 
Net Income2.0B1.3B3.1B1.6B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS872.0M849.0M853.0M855.0M
 
 
 
 
 
Shares To Calculate EPS Diluted873.0M850.0M858.0M864.0M
 
 
 
 
 
 
Earnings Per ShareEPS$2.25$1.49$3.58$1.84
 
 
 
 
 
EPS Diluted$2.25$1.49$3.56$1.82